Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Diagnosis (Laboratory Tests, Imaging Tests); Indication (Pain and Cramping, Diarrhea, Constipation, Alternating Constipation and Diarrhea), and Geography

Publication Month: Mar 2021 | Report Code: TIPRE00016657 | No. of Pages: 185 | Category: Medical Device | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

Irritable bowel syndrome (IBS) diagnostics market was valued at US$ 2,470.61 million in 2020 and is projected to reach US$ 3,880.91 million by 2028; it is expected to grow at a CAGR of 5.9% from 2021 to 2028.

 

Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.

  

Irritable bowel syndrome (IBS) diagnostics market is segmented on the basis of diagnosis, indication, and geography. By geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the irritable bowel syndrome (IBS) diagnostics market, emphasizing on parameters such as market trends, technological advancements, and market dynamics along with the analysis of competitive landscape of world’s leading market players.    

 

Irritable Bowel Syndrome (IBS) Diagnostics Market

Irritable Bowel Syndrome (IBS) Diagnostics Market

Get more information on this report :


 

Market Insights

Irritable bowel syndrome is a chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping.

People across the world are witnessing considerable incidence of irritable bowel syndrome. According to the data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients, about 40% of people have mild IBS, around 35% have moderate IBS, and an estimated 25% have severe IBS. Food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. According to a study published on NCBI in 2018, irritable bowel syndrome is estimated to affect around 10–16% of the US population each year. Further, as per the IBS Global Impact Report, in 2016, an estimated mean prevalence of individual countries ranged from 1.1% in France and Iran to 35.5% in Mexico. Latin America had a prevalence rate of 17.5%, Asia 9.6%, North America/Europe/Australia/New Zealand 7.1%, and the Middle East & Africa had a prevalence rate of 5.8%.  Such staggering prevalence of irritable bowel syndrome is likely to boost the irritable bowel syndrome (IBS) diagnostics market during the forecast period.

 

To cope up against irritable bowel syndrome, the market players are taking constructive steps to create programs to spread awareness among the population. For instance, in 2018, the collaboration of Allergan PLC and Ironwood launched an Interactive Digital Destination platform to encourage sufferers to get educated and act. Similarly, in January 2018, Commonwealth Diagnostics International, Inc. collaborated with American professional golfer, Rob Oppenheim to raise awareness about irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO).

                       

Increasing Number of FDA Approvals and Diagnostics Developments Contribute Significantly to Market Growth

Increasing number of FDA approvals and diagnostics development activities are likely to accelerate the growth of the irritable bowel syndrome (IBS) diagnostics market during the forecast period. Majority of the established as well as new players are coming forward to develop and manufacture diagnostic solutions for the disease, which will lead to ample availability of the diagnostic solutions in the market. For instance, in February 2020, Commonwealth Diagnostics International (CDI), Inc. re-launched the IBSchek, the first clinically validated biomarker blood test for mixed-type irritable bowel syndrome (IBS-D, IBS-M) and diarrhea-predominant in a new at-home capillary collection kit. Further, in October 2018, Gemelli Biotech launched the IBS-smart, an innovation in blood testing for irritable bowel syndrome (IBS), in partnership with Medically Associated Science and Technology Program (MAST) at Cedars-Sinai.

The irritable bowel syndrome (IBS) diagnostics market is projected to witness approvals of diagnostic solutions, which will eventually have a positive impact on the growth of the market. For instance, in June 2019, BÜHLMANN Laboratories AG received United States Food and Drug Administration (FDA) 510(k) clearance for its BÜHLMANN fCAL turbo Automated Calprotectin Test and BÜHLMANN fCAL ELISA Calprotectin Test. According to company estimates, the test is anticipated to observe thriving sales in the global market.

             

Diagnosis Insights            

Based on diagnosis, the global irritable bowel syndrome (IBS) diagnostics market is segmented into laboratory tests and imaging tests. In 2020, the laboratory tests segment held the largest share in the market. Moreover, the segment is expected to hold the largest market share by 2028. The market growth is mainly attributed to the growing prevalence of irritable bowel syndrome (IBS) worldwide, which is likely to continue in the coming years due to disturbances in bowel habits and abdominal pain. This, in turn, is boosting the demand for diagnosis of these diseases worldwide.

                             

Indication Insights

Based on indication, the global irritable bowel syndrome (IBS) diagnostics market is segmented into pain and cramping, diarrhea, constipation, and alternating constipation and diarrhea. The pain and cramping segment held the largest market share in 2020, and it is further expected to dominate the market by 2028. Antispasmodics and antidepressants are medication used to treat IBS pain and cramping.    

 

Irritable Bowel Syndrome (IBS) Diagnostics Market, by Treatment – 2020 and 2028

Irritable Bowel Syndrome (IBS) Diagnostics Market, by Treatment – 2020 and 2028

Get more information on this report :


                                               

Strategic Insights

Product launches, and mergers and acquisitions are highly adopted strategies in the global irritable bowel syndrome (IBS) diagnostics market. A few of the recent key product developments are listed below:

 

In February 2020, Commonwealth Diagnostics International (CDI), Inc., announced the commercial re-launch of IBSchek, the first clinically validated biomarker blood test for diarrhea-predominant and mixed-type irritable bowel syndrome (IBS-D, IBS-M) in a new at-home capillary collection kit.

 

In January 2019, Gemelli Biotech announced a partnership with Kuwait-based Advanced Medical German Co. (AMG), one of the leading international distributors of medical products and services in the Middle East. Through the partnership, AMG will distribute Gemelli's proprietary diagnostic blood test for IBS, ibs-smart, in major territories in the Middle East and North Africa, including Kuwait, the UAE, Qatar, Saudi Arabia, Egypt, and Turkey.

 

The COVID-19 pandemic is estimated to have a significant positive impact on the irritable bowel syndrome (IBS) diagnostics market. Majority of the pharmaceutical companies across the world are engaged in the development of vaccines for COVID-19. Moreover, irritable bowel syndrome (IBS) is frequently triggered by COVID-19 stress. Thus, home testing kits are preferable to laboratory testing as laboratory services may be overwhelmed in the pandemic, which is anticipated to have a positive impact on the other segments of the market in the coming months. However, disruptions in the supply chain caused due to the halt in global operations are hindering the market growth. 

 

Irritable Bowel Syndrome (IBS) Diagnostics – Market Segmentation

 

By Diagnosis

  • Laboratory Tests
    • Lactose Intolerance Tests
    • Breath Test for Bacterial Overgrowth
    • Stool Tests
    • Blood Tests
  • Imaging Tests
    • CT Scan or X-Ray
    • Upper Endoscopy
    • Colonoscopy

By Indication

  • Pain and Cramping
  • Diarrhea
  • Constipation
  • Alternating Constipation and Diarrhea

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East & Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Commonwealth Diagnostics International
  • Genova Diagnostics
  • Gemelli Biotech
  • Prometheus Laboratories
  • Inova Diagnostics, Inc.
  • Biohit Oyj
  • Aerodiagnostics, LLC.
  • Metabolic Solutions, Inc.
  • Sysmex Corporation
  • Bühlmann Laboratories AG

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Irritable Bowel Syndrome (IBS) Diagnostics Market – By Diagnosis

1.3.2        Global Irritable Bowel Syndrome (IBS) Diagnostics Market – By Indication

1.3.3        Global Irritable Bowel Syndrome (IBS) Diagnostics Market– By Geography

2.             Irritable Bowel Syndrome (IBS) Diagnostics Market– Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Irritable Bowel Syndrome (IBS) Diagnostics Market– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America PEST Analysis

4.2.2        Europe PEST Analysis

4.2.3        APAC PEST Analysis

4.2.4        MEA PEST Analysis

4.2.5        SCAM PEST Analysis

4.3       Expert Opinion

5.             Irritable Bowel Syndrome (IBS) Diagnostics Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions

5.1.2        Increasing number of FDA approvals and diagnostics developments

5.2       Market Restraint

5.2.1        Challenges in Diagnosis of IBS

5.3       Market Opportunity

5.3.1        Increasing disposable incomes of the population

5.4       Future Trend

5.4.1        Development of medical devices for the diagnosis of irritable bowel syndrome

5.5       Impact analysis

6.             Irritable Bowel Syndrome (IBS) Diagnostics Market– Global Analysis

6.1       Global Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Forecast and Analysis

6.2       Global Irritable Bowel Syndrome (IBS) Diagnostics Market, By Geography - Forecast and Analysis

6.3       Market Positioning of Key Players

7.             Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis– by Diagnosis

7.1       Overview

7.2       Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)

7.3       Laboratory Tests

7.3.1        Overview

7.3.2        Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Lactose Intolerance Tests

7.3.3.1      Overview

7.3.3.2      Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Breath Test for Bacterial Overgrowth

7.3.4.1      Overview

7.3.4.2      Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5        Stool Tests

7.3.5.1      Overview

7.3.5.2      Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.6        Blood Tests

7.3.6.1      Overview

7.3.6.2      Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4       Imaging Tests

7.4.1        Overview

7.4.2        Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        CT-Scan or X-Ray

7.4.3.1      Overview

7.4.3.2      CT-Scan or X-Ray: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Upper Endoscopy

7.4.4.1      Overview

7.4.4.2      Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Colonoscopy

7.4.5.1      Overview

7.4.5.2      Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.             Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – By Indication

8.1       Overview

8.2       Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)

8.3       Pain and Cramping

8.3.1        Overview

8.3.2        Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Diarrhea

8.4.1        Overview

8.4.2        Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Constipation

8.5.1        Overview

8.5.2        Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.6       Alternating Constipation and Diarrhea

8.6.1        Overview

8.6.2        Alternating Constipation and Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

9.             Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis and Forecasts To 2028 – Geographical Analysis

9.1       North America: Irritable Bowel Syndrome (IBS) Diagnostics Market

9.1.1        Overview

9.1.2        North America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.3        North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.1.3.1      North America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.3.2      North America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.4        North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, By Indication – Revenue and Forecast to 2028 (USD Million)

9.1.5        North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)

9.1.6        US: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.6.1      US: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.6.2      US: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)

9.1.6.2.1       US: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2       US: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.6.3      US: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication– Revenue and Forecast to 2028 (USD Million)

9.1.7        Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.7.1      Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.7.2      Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)

9.1.7.2.1       Canada: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2       Canada: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.7.3      Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

9.1.8        Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.8.1      Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.8.2      Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.1.8.2.1       Mexico: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2       Mexico: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.3      Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

9.2       Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market

9.2.1        Overview

9.2.2        Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.3        Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.2.3.1      Europe: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.3.2      Europe: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.4        Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028  (USD Million)

9.2.5        Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028(%)

9.2.6        Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.6.1      Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.6.2      Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.2.6.2.1       Germany: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.6.2.2       Germany: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.6.3      Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

9.2.7        France: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.7.1      France: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.7.2      France: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.2.7.2.1       France: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.7.2.2       France: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.7.3      France: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

9.2.8        UK: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.8.1      UK: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.8.2      UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.2.8.2.1       UK: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.8.2.2       UK: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.8.3      UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

9.2.9        Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.9.1      Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.9.2      Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.2.9.2.1       Italy: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.9.2.2       Italy: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.9.3      Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

9.2.10     Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.10.1    Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.10.2    Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.2.10.2.1    Spain: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.10.2.2    Spain: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.10.3    Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

9.2.11     Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.11.1    Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.2.11.2    Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.2.11.2.1    Rest of Europe: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.11.2.2    Rest of Europe: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.2.11.3    Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)0

9.3       Asia Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market1

9.3.1        Overview1

9.3.2        Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)2

9.3.3        Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)2

9.3.3.1      Asia-Pacific: Laboratory Tests Market, by Type, 2019–2028 (USD Million)3

9.3.3.2      Asia-Pacific: Imaging Tests Market, by Type, 2019–2028 (USD Million)3

9.3.4        Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)4

9.3.5        Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)4

9.3.6        China: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)5

9.3.6.1      China: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)5

9.3.6.2      China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)6

9.3.6.2.1       China: Laboratory Tests Market, by Type, 2019–2028 (USD Million)6

9.3.6.2.2       China: Imaging Tests Market, by Type, 2019–2028 (USD Million)6

9.3.6.3      China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)7

9.3.7        Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)8

9.3.7.1      Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)8

9.3.7.2      Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)9

9.3.7.2.1       Japan: Laboratory Tests Market, by Type, 2019–2028 (USD Million)9

9.3.7.2.2       Japan: Imaging Tests Market, by Type, 2019–2028 (USD Million)9

9.3.7.3      Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)9

9.3.8        India: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)1

9.3.8.1      India: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)1

9.3.8.2      India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)2

9.3.8.2.1       India: Laboratory Tests Market, by Type, 2019–2028 (USD Million)2

9.3.8.2.2       India:  Imaging Tests Market, by Type, 2019–2028 (USD Million)2

9.3.8.3      India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)3

9.3.9        Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)4

9.3.9.1      Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)4

9.3.9.2      Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)5

9.3.9.2.1       Australia: Laboratory Tests Market, by Type, 2019–2028 (USD Million)5

9.3.9.2.2       Australia: Imaging Tests Market, by Type, 2019–2028 (USD Million)5

9.3.9.3      Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)6

9.3.10     South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7

9.3.10.1    South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7

9.3.10.2    South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)8

9.3.10.2.1    South Korea: Laboratory Tests Market, by Type, 2019–2028 (USD Million)8

9.3.10.2.2    South Korea: Imaging Tests Market, by Type, 2019–2028 (USD Million)9

9.3.10.3    South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)9

9.3.11     Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0

9.3.11.1    Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0

9.3.11.2    Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)1

9.3.11.2.1    Rest of Asia-Pacific: Laboratory Tests Market, by Type, 2019–2028 (USD Million)1

9.3.11.2.2    Rest of Asia-Pacific: Imaging Tests Market, by Type, by Imaging Tests, 2019–2028 (USD Million)2

9.3.11.3    Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)2

9.4       Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market3

9.4.1        Overview3

9.4.2        Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)4

9.4.3        Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4

9.4.3.1      Middle East and Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5

9.4.3.2      Middle East and Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5

9.4.4        Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)6

9.4.5        Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)6

9.4.6        Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7

9.4.6.1      Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7

9.4.6.2      Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)8

9.4.6.2.1       Saudi Arabia: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8

9.4.6.2.2       Saudi Arabia: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8

9.4.6.3      Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)9

9.4.7        South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0

9.4.7.1      South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0

9.4.7.2      South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)1

9.4.7.2.1       South Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1

9.4.7.2.2       South Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1

9.4.7.3      South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)2

9.4.8        UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)3

9.4.8.1      UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)3

9.4.8.2      UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4

9.4.8.2.1       UAE: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)4

9.4.8.2.2       UAE: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5

9.4.8.3      UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)5

9.4.9        Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6

9.4.9.1      Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6

9.4.9.2      Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)7

9.4.9.2.1       Rest of Middle East and Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7

9.4.9.2.2       Rest of Middle East and Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7

9.4.9.3      Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)8

9.5       South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market9

9.5.1        Overview9

9.5.2        South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0

9.5.3        South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)0

9.5.3.1      South And Central America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1

9.5.3.2      South And Central America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1

9.5.4        South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)2

9.5.5        South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)3

9.5.6        Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)3

9.5.6.1      Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)3

9.5.6.2      Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4

9.5.6.2.1       Brazil: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)4

9.5.6.2.2       Brazil: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5

9.5.6.3      Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)5

9.5.7        Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6

9.5.7.1      Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6

9.5.7.2      Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)7

9.5.7.2.1       Argentina: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7

9.5.7.2.2       Argentina: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8

9.5.7.3      Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)8

9.5.8        Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)9

9.5.8.1      Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)9

9.5.8.2      Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)0

9.5.8.2.1       Rest of South And Central America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)0

9.5.8.2.2       Rest of South And Central America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1

9.5.8.3      Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

10.          Impact of COVID-19 Pandemic on Global Irritable Bowel Syndrome (IBS) Diagnostics Market2

10.1    North America: Impact Assessment of COVID-19 Pandemic2

10.2    Europe: Impact Assessment of COVID-19 Pandemic4

10.3    Asia Pacific: Impact Assessment of COVID-19 Pandemic6

10.4    Middle East and Africa: Impact Assessment of COVID-19 Pandemic7

10.5    South and Central America: Impact Assessment of COVID-19 Pandemic8

11.          Irritable Bowel Syndrome (IBS) Diagnostics Market– Industry Landscape9

11.1    Overview9

11.2    Growth Strategies Done by the Companies in the Market, (%)9

11.3    Organic Developments0

11.3.1     Overview0

11.4    Inorganic Developments1

11.4.1     Overview1

12.          Company Profiles2

12.1    Commonwealth Diagnostics International2

12.1.1     Key Facts2

12.1.2     Business Description2

12.1.3     Products and Services2

12.1.4     Financial Overview2

12.1.5     SWOT Analysis3

12.1.6     Key Developments3

12.2    Genova Diagnostics5

12.2.1     Key Facts5

12.2.2     Business Description5

12.2.3     Products and Services5

12.2.4     Financial Overview5

12.2.5     SWOT Analysis6

12.2.6     Key Developments6

12.3    Gemelli Biotech7

12.3.1     Key Facts7

12.3.2     Business Description7

12.3.3     Products and Services7

12.3.4     Financial Overview7

12.3.5     SWOT Analysis8

12.3.6     Key Developments8

12.4    Prometheus Laboratories9

12.4.1     Key Facts9

12.4.2     Business Description9

12.4.3     Products and Services9

12.4.4     Financial Overview9

12.4.5     SWOT Analysis0

12.4.6     Key Developments0

12.5    Inova Diagnostics, Inc.1

12.5.1     Key Facts1

12.5.2     Business Description1

12.5.3     Products and Services1

12.5.4     Financial Overview1

12.5.5     SWOT Analysis2

12.5.6     Key Developments2

12.6    Biohit Oyj3

12.6.1     Key Facts3

12.6.2     Business Description3

12.6.3     Products and Services3

12.6.4     Financial Overview4

12.6.5     SWOT Analysis5

12.6.6     Key Developments5

12.7    Aerodiagnostics, LLC.6

12.7.1     Key Facts6

12.7.2     Business Description6

12.7.3     Products and Services6

12.7.4     Financial Overview6

12.7.5     SWOT Analysis7

12.7.6     Key Developments7

12.8    Metabolic Solutions, Inc.8

12.8.1     Key Facts8

12.8.2     Business Description8

12.8.3     Products and Services8

12.8.4     Financial Overview8

12.8.5     SWOT Analysis9

12.8.6     Key Developments9

12.9    Sysmex Corporation (Sysmex Europe GmbH)9

12.9.1     Key Facts9

12.9.2     Business Description9

12.9.3     Products and Services0

12.9.4     Financial Overview0

12.9.5     SWOT Analysis2

12.9.6     Key Developments2

12.10 BÜHLMANN Laboratories AG3

12.10.1   Key Facts3

12.10.2   Business Description3

12.10.3   Products and Services3

12.10.4   Financial Overview3

12.10.5   SWOT Analysis4

12.10.6   Key Developments4

13.          Appendix5

13.1    About the Insight Partners5

13.2    Glossary of Terms5


LIST OF TABLES

Table 1.             North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 2.             North America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             US: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)

Table 6.             US: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             US: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             US: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication-Revenue and Forecast to 2028 (USD Million)

Table 9.             Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)

Table 10.          Canada: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 13.          Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 14.          Mexico: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          Mexico: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 17.          Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 18.          Europe: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          Europe: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 20.          Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 21.          Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 22.          Germany: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 23.          Germany: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 24.          Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 25.          France: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 26.          France: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 27.          France: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 28.          France: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 29.          UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 30.          UK: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 31.          UK: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 32.          UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 33.          Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 34.          Italy: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 35.          Italy: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 36.          Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 37.          Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 38.          Spain: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 39.          Spain: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 40.          Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 41.          Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 42.          Rest of Europe: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 43.          Rest of Europe: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 44.          Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)0

Table 45.          Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)2

Table 46.          Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)3

Table 47.          Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)3

Table 48.          Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)4

Table 49.          China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)6

Table 50.          China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)6

Table 51.          China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)6

Table 52.          China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)7

Table 53.          Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)9

Table 54.          Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)9

Table 55.          Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)9

Table 56.          Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)0

Table 57.          India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)2

Table 58.          India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)2

Table 59.          India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)2

Table 60.          India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)3

Table 61.          Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)5

Table 62.          Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)5

Table 63.          Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)5

Table 64.          Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)6

Table 65.          South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)8

Table 66.          South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)8

Table 67.          South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)9

Table 68.          South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)9

Table 69.          Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)1

Table 70.          Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)1

Table 71.          Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)2

Table 72.          Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)2

Table 73.          Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4

Table 74.          Middle East and Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5

Table 75.          Middle East and Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5

Table 76.          Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)6

Table 77.          Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)8

Table 78.          Saudi Arabia: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8

Table 79.          Saudi Arabia: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8

Table 80.          Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)9

Table 81.          South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)1

Table 82.          South Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1

Table 83.          South Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1

Table 84.          South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)2

Table 85.          UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4

Table 86.          UAE: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)4

Table 87.          UAE: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5

Table 88.          UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)5

Table 89.          Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)7

Table 90.          Rest of Middle East and Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7

Table 91.          Rest of Middle East and Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7

Table 92.          Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)8

Table 93.          South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)0

Table 94.          South And Central America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1

Table 95.          South And Central America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1

Table 96.          South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)2

Table 97.          Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4

Table 98.          Brazil: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)4

Table 99.          Brazil: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5

Table 100.       Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)5

Table 101.       Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)7

Table 102.       Argentina: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7

Table 103.       Argentina: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8

Table 104.       Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)8

Table 105.       Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)0

Table 106.       Rest of South And Central America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)0

Table 107.       Rest of South And Central America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1

Table 108.       Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)1

Table 109.       Organic Developments Done By Companies0

Table 110.       Inorganic Developments Done By Companies1

Table 111.       Glossary of Terms, Irritable Bowel Syndrome (IBS) Diagnostics Market5

 

LIST OF FIGURES

Figure 1.           Irritable Bowel Syndrome (IBS) Diagnostics Market Segmentation

Figure 2.           Irritable Bowel Syndrome (IBS) Diagnostics Segmentation, By Region

Figure 3.           Global Irritable Bowel Syndrome (IBS) Diagnostics Market Overview

Figure 4.           Laboratory Tests Systems Held Largest Share of Diagnosis Segment in Irritable Bowel Syndrome (IBS) Diagnostics Market

Figure 5.           Asia Pacific to Show Remarkable Growth During Forecast Period

Figure 6.           Irritable Bowel Syndrome (IBS) Diagnostics Market, by Geography (US$ Million)

Figure 7.           Global Irritable Bowel Syndrome (IBS) Diagnostics Market– Leading Country Markets (US$ Million)

Figure 8.           Global Irritable Bowel Syndrome (IBS) Diagnostics Market, Industry Landscape

Figure 9.           North America: PEST Analysis

Figure 10.        Europe: PEST Analysis

Figure 11.        APAC: PEST Analysis

Figure 12.        MEA: PEST Analysis

Figure 13.        SCAM: PEST Analysis

Figure 14.        Irritable Bowel Syndrome (IBS) Diagnostics Market Impact Analysis of Driver and Restraints

Figure 15.        Global Irritable Bowel Syndrome (IBS) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 16.        Global Irritable Bowel Syndrome (IBS) Diagnostics Market– By Geography Forecast and Analysis – 2020- 2028

Figure 17.        Market Positioning of Key Players in Global Irritable Bowel Syndrome (IBS) Diagnostics Market

Figure 18.        Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)

Figure 19.        Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        CT-Scan or X-Ray: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)

Figure 29.        Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Alternating Constipation and Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33.        North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)

Figure 34.        North America: Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 35.        North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)

Figure 36.        US: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)

Figure 40.        Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 41.        Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)

Figure 42.        Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 43.        France: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 44.        UK: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 45.        Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 46.        Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 47.        Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 48.        Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)1

Figure 49.        Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2027 (USD Million)2

Figure 50.        Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)4

Figure 51.        China: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)5

Figure 52.        Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)8

Figure 53.        India: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)1

Figure 54.        Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)4

Figure 55.        South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7

Figure 56.        Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0

Figure 57.        Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)3

Figure 58.        Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2027 (USD Million)4

Figure 59.        Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)6

Figure 60.        Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7

Figure 61.        South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0

Figure 62.        UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)3

Figure 63.        Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6

Figure 64.        South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)9

Figure 65.        South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2028 (USD Million)0

Figure 66.        South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)3

Figure 67.        Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)4

Figure 68.        Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6

Figure 69.        Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)9

Figure 70.        Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in North American Countries3

Figure 71.        Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in European Countries5

Figure 72.        Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Asia Pacific Countries6

Figure 73.        Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Rest of the World7

Figure 74.        Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Rest of the World8

Figure 75.             Growth Strategies Done by the Companies in the Market, (%)

 

1

The List of Companies - Irritable Bowel Syndrome (IBS) Diagnostics Market

  1. Commonwealth Diagnostics International
  2. Genova Diagnostics
  3. Gemelli Biotech
  4. Prometheus Laboratories
  5. Inova Diagnostics, Inc.
  6. Biohit Oyj
  7. Aerodiagnostics, LLC.
  8. Metabolic Solutions, Inc.
  9. Sysmex Corporation
  10. BÜHLMANN Laboratories AG.

 

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the irritable bowel syndrome (IBS) diagnostics market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global irritable bowel syndrome (IBS) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPRE00016657
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Irritable bowel syndrome (IBS) is defined as gastro-intestinal disorder causing discomfort in the stomach, along with wind, diarrhoea and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. Moreover, IBS diagnostics is done through medical history, physical exam and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test and stool test. The tests are done based on the symptoms such as constipation-predominant, diarrhea-predominant or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy and colonoscopy.

The factors that are driving growth of the market are increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics developments are anticipated to drive the growth of the global irritable bowel syndrome (IBS) diag nostics market during the forecast period. However, challenges in diagnosis of IBS are hindering the market growth.

The irritable bowel syndrome (IBS) diagnostics market majorly consists of the players such Commonwealth Diagnostics International, Genova Diagnostics, Gemelli Biotech, Prometheus Laboratories, Inova Diagnostics, Inc., Biohit Oyj, Aerodiagnostics, LLC., Metabolic Solutions, Inc., Sysmex Corporation, BÃœHLMANN Laboratories AG are among others.

Pricing